Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas

Gynecologic Oncology

Volumn 100, Issue 2, 2006, Pages 264-270

  Brown, Lindsay A ^a   Irving, Julie ^a   Parker, Robin ^b   Kim, Hanna ^c   Press, Joshua Z ^a   Longacre, Teri A ^c   Chia, Stephen ^d   Magliocco, Anthony ^b   Makretsov, Nikita ^e   Gilks, Blake ^a   Pollack, Jonathan ^c   Huntsman, David ^a,d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BRITISH COLUMBIA CANCER AGENCY   (Canada)

^e MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Fluorescent in situ hybridization; Gene amplification; Novel oncogene; Tissue arrays

Indexed keywords

BRCA2 PROTEIN; COMPLEMENTARY DNA; CYCLIN D1; P21 ACTIVATED KINASE 1; PROTEIN CDC42; PROTEIN EMSY; PROTEIN P21; PROTEIN SERINE KINASE; RNA; UNCLASSIFIED DRUG;

AMPLICON; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CLEAR CELL CARCINOMA; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE EXPRESSION; GENE FUNCTION; GENE LOCATION; GENE LOCUS; GENE MAPPING; GENE NUMBER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ONCOGENE; OVARY CARCINOMA; PAPILLARY CARCINOMA; PRIORITY JOURNAL; TISSUE MICROARRAY; UNDIFFERENTIATED CARCINOMA;

CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 11; FEMALE; GENE AMPLIFICATION; GENE DOSAGE; GENES, BCL-1; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; NEOPLASM PROTEINS; NUCLEAR PROTEINS; ONCOGENES; OVARIAN NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; REPRESSOR PROTEINS;

EID: 30444457408     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.08.026     Document Type: Article

References (33)

1. G. Peters, V. Fantl, R. Smith, S. Brookes, and C. Dickson Chromosome 11q13 markers and D-type cyclins in breast cancer Breast Cancer Res. Treat. 33 2 1995 125 135
2. J. Karlseder, R. Zeillinger, and C. Schneeberger Patterns of DNA amplification at band q13 of chromosome 11 in human breast cancer Genes Chromosomes Cancer 9 1 1994 42 48
3. R. Hui, D.H. Campbell, and C.S. Lee EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer Oncogene 15 13 1997 1617 1623
4. S. Bekri, J. Adelaide, and S. Merscher Detailed map of a region commonly amplified at 11q13 → q14 in human breast carcinoma Cytogenet. Cell Genet. 79 1-2 1997 125 131
5. C.J. Ormandy, E.A. Musgrove, R. Hui, R.J. Daly, and R.L. Sutherland Cyclin D1, EMS1 and 11q13 amplification in breast cancer Breast Cancer Res. Treat. 78 3 2003 323 335
6. R. Hui, J.R. Ball, R.D. Macmillan, F.S. Kenny, O.W. Prall, and D.H. Campbell EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survival Oncogene 8 27 1998 (Aug 17) 1053 1059
7. S.D. Worsley, B.A. Ponder, and B.R. Davies Overexpression of cyclin D1 in epithelial ovarian cancers Gynecol. Oncol. 64 2 1997 189 195
8. L. Hughes-Davies, D. Huntsman, and M. Ruas EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer Cell 115 5 2003 523 535
9. C. Rodriguez, L. Hughes-Davies, H. Valles, B. Orsetti, M. Cuny, and L. Ursule Amplification of the BRCA2 pathway gene EMSY in sporadic breast cancer is related to negative outcome Clin. Cancer Res. 17 1 2004 (Sep 10) 5785 5791
10. P. Schraml, G. Schwerdtfeger, and F. Burkhalter Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma Am. J. Pathol. 163 3 2003 985 992
11. R.L. Parker, D.G. Huntsman, and D.W. Lesack Assessment of interlaboratory variation in the immunohistochemical determination of estrogen receptor status using a breast cancer tissue microarray Am. J. Clin. Pathol. 161 2002 1557 1564
12. C.M. Perou, T. Sorlie, and M.B. Eisen Molecular portraits of human breast tumours Nature 406 6797 2000 747 752
13. J.R. Pollack, T. Sorlie, and C.M. Perou Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors Proc. Natl. Acad. Sci. U. S. A. 99 20 2002 12963 12968
14. E. Schuuring, E. Verhoeven, H. van Tinteren, J.L. Peterse, B. Nunnink, and F.B. Thunnissen Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer Cancer Res. 52 19 1992 (Oct 1) 5229 5234
15. E. Schuuring, E. Verhoeven, W.J. Mooi, and R.J. Michalides Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas Oncogene 7 2 1992 355 361
16. V. Baldin, J. Lukas, M.J. Marcote, M. Pagano, and G. Draetta Cyclin D1 is a nuclear protein required for cell cycle progression in G1 Genes Dev. 5 1993 (May 7) 812 821
17. W. Jiang, S.M. Kahn, P. Zhou, Y.J. Zhang, A.M. Cacace, and A.S. Infante Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression Oncogene 12 1993 (Dec 8) 3447 3457
18. A. Almasan, S.P. Linke, T.G. Paulson, L.C. Huang, and G.M. Wahl Genetic instability as a consequence of inappropriate entry into and progression through S-phase Cancer Metastasis Rev. 1 1995 (Mar 14) 59 73 [Review]
19. G.A. Lammie, and G. Peters Chromosome 11q13 abnormalities in human cancer Cancer Cells 11 1991 (Nov 3) 413 420 [Review]
20. M.H. Champeme, I. Bieche, S. Lizard, and R. Lidereau 11q13 amplification in local recurrence of human primary breast cancer Genes Chromosomes Cancer 2 1995 (Feb 12) 128 133
21. F. Courjal, M. Cuny, and J. Simony-Lafontaine Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups Cancer Res. 57 19 1997 4360 4367
22. M.F. Buckley, K.J. Sweeney, J.A. Hamilton, R.L. Sini, D.L. Manning, and R.I. Nicholson Expression and amplification of cyclin genes in human breast cancer Oncogene 8 1993 (Aug 8) 2127 2133
23. C. Gillett, V. Fantl, R. Smith, C. Fisher, J. Bartek, and C. Dickson Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining Cancer Res. 54 7 1994 (Apr 1) 1812 1817
24. V. Fantl, M.A. Richards, R. Smith, G.A. Lammie, G. Johnstone, and D. Allen Gene amplification on chromosome band 11q13 and oestrogen receptor status in breast cancer Eur. J. Cancer 4 1990 (Apr 26) 423 429
25. E. Schuuring, E. Verhoeven, S. Litvinov, and R.J. Michalides The product of the EMS1 gene, amplified and overexpressed in human carcinomas, is homologous to a v-src substrate and is located in cell-substratum contact sites Mol. Cell. Biol. 5 1993 (May 13) 2891 2898
26. S.C. Rubin BRCA-related ovarian carcinoma Cancer 97 9 2003 2127 2129
27. P.D. Pharoah, D.F. Easton, D.L. Stockton, S. Gayther, and B.A. Ponder Survival in familial, BRCA1-associated, and BRCA2-associated epithelial ovarian cancer. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group Cancer Res. 59 4 1999 868 871
28. H.A. Risch, J.R. McLaughlin, and D.E. Cole Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer Am. J. Hum. Genet. 68 3 2001 700 710
29. D.M. Livingston EMSY, a BRCA-2 partner in crime Nat. Med. 2 2004 (Feb 10) 127 128
30. M.C. King A novel BRCA2-binding protein and breast and ovarian tumorigenesis N. Engl. J. Med. 350 12 2004 (Mar 18) 1252 1253
31. N. Turner, A. Tutt, and A. Ashworth Hallmarks of 'BRCAness' in sporadic cancers Nat. Rev. Cancer 10 2004 (Oct 4) 814 819
32. L. Adam, R. Vadlamudi, S.B. Kondapaka, J. Chernoff, J. Mendelsohn, and R. Kumar Heregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-1 via phosphatidylinositol-3 kinase J. Biol. Chem. 43 23 1998 (Oct 273) 28238 28246
33. L. Adam, R. Vadlamudi, M. Mandal, J. Chernoff, and R. Kumar Regulation of microfilament reorganization and invasiveness of breast cancer cells by kinase dead p21-activated kinase-1 J. Biol. Chem. 275 16 2000 (Apr 21) 12041 12050